Lucassin terlipressin: Phase III started

Ikaria began the double-blind, placebo-controlled, U.S. Phase III REVERSE trial to evaluate IV Lucassin in 180 patients receiving standard of care albumin therapy. Terlipressin has Fast Track and Orp...